These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20940533)

  • 1. Frequency and significance of unrecognized chronic obstructive pulmonary disease in elderly patients with stable heart failure.
    Apostolovic S; Jankovic-Tomasevic R; Salinger-Martinovic S; Djordjevic-Radojkovic D; Stanojevic D; Pavlovic M; Stankovic I; Putnikovic B; Kafedzic S; Catovic S; Tahirovic E; Düngen HD
    Aging Clin Exp Res; 2011; 23(5-6):337-42. PubMed ID: 20940533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
    Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistent chronic obstructive pulmonary disease and heart failure in the elderly.
    Padeletti M; Jelic S; LeJemtel TH
    Int J Cardiol; 2008 Apr; 125(2):209-15. PubMed ID: 18221802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.
    Beghé B; Fabbri LM; Garofalo M; Schito M; Verduri A; Bortolotti M; Stendardo M; Ruggieri V; Fucili A; Sverzellati N; Della Casa G; Maietti E; Clini EM; Boschetto P
    Respiration; 2019; 97(3):223-233. PubMed ID: 30205380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the feasibility to combine patients with chronic obstructive pulmonary disease and chronic heart failure in self-management groups with focus on exercise self-efficacy.
    Giezeman M; Theander K; Zakrisson AB; Sundh J; Hasselgren M
    Scand J Prim Health Care; 2022 Jun; 40(2):208-216. PubMed ID: 35575429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic heart failure modifies the response to positive end-expiratory pressure in patients with chronic obstructive pulmonary disease.
    Bihari S; Bersten AD
    J Crit Care; 2012 Dec; 27(6):639-46. PubMed ID: 22595206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
    Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waist circumference does not correlate with functional lung capacity in moderate and severe chronic obstructive pulmonary disease.
    Popović-Grle S; Ladić A; Butorac-Petanjek B; Spicek-Macan J; Cucević B
    Acta Clin Croat; 2013 Mar; 52(1):69-77. PubMed ID: 23837275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COPD in patients with stable heart failure in the primary care setting.
    Valk MJ; Broekhuizen BD; Mosterd A; Zuithoff NP; Hoes AW; Rutten FH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1219-24. PubMed ID: 26170650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
    Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
    J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD?
    Sun KS; Lin MS; Chen YJ; Chen YY; Chen SC; Chen W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1487-92. PubMed ID: 26251588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
    Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
    Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of comorbidities in COPD clinical control criteria. The CLAVE study.
    Almagro P; Soler-Cataluña JJ; Huerta A; González-Segura D; Cosío BG;
    BMC Pulm Med; 2024 Jan; 24(1):6. PubMed ID: 38166965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia.
    Andrianopoulos V; Franssen FM; Peeters JP; Ubachs TJ; Bukari H; Groenen M; Burtin C; Vogiatzis I; Wouters EF; Spruit MA
    Respir Physiol Neurobiol; 2014 Jan; 190():40-6. PubMed ID: 24121092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.
    Kerti M; Balogh Z; Kelemen K; Varga JT
    Int J Chron Obstruct Pulmon Dis; 2018; 13():717-724. PubMed ID: 29535512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.